Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Dechra launches new monitoring method for dogs with Cushing’s syndrome

Dechra launches new monitoring method for dogs with Cushing’s syndrome

10th April 2018

Dechra has announced the launch of a new and improved method for monitoring dogs that are being treated for Cushing's syndrome with the company's Vetoryl product.

The Pre-Vetoryl Cortisol (PVC) monitoring information has been developed by the company in cooperation with Professor Ian Ramsey at the University of Glasgow, and is being offered online alongside a suite of other useful resources for patients on Vetoryl.

This new method has been introduced following recent studies showing a lack of correlation between traditional ACTH stimulation test results and the clinical status of dogs receiving Vetoryl, whereas PVC monitoring delivers better results by placing a greater focus on the importance of consulting with the owners regarding the dog's clinical response at home.

Craig Sankey, brand manager at Dechra Veterinary Products, said: "Pre-Vetoryl Cortisol monitoring is a reliable alternative to traditional ACTH stimulation tests for several reasons. It predicts clinical signs better, gives more consistent results, is less expensive and is easier to perform."

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips and straight to your inbox.